标题
Long-term effects of cariprazine exposure on dopamine receptor subtypes
作者
关键词
-
出版物
CNS SPECTRUMS
Volume 19, Issue 03, Pages 268-277
出版商
Cambridge University Press (CUP)
发表日期
2013-11-08
DOI
10.1017/s1092852913000680
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Cariprazine in Schizophrenia: Clinical Efficacy, Tolerability, and Place in Therapy
- (2013) Leslie Citrome ADVANCES IN THERAPY
- Cariprazine in Bipolar Disorder: Clinical Efficacy, Tolerability, and Place in Therapy
- (2013) Leslie Citrome ADVANCES IN THERAPY
- Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview
- (2012) V. V. Dias et al. ACTA PSYCHIATRICA SCANDINAVICA
- Pharmacokinetics and metabolism update for some recent antipsychotics
- (2011) Silvio Caccia Expert Opinion on Drug Metabolism & Toxicology
- Emerging drugs for schizophrenia
- (2011) Falko Biedermann et al. EXPERT OPINION ON EMERGING DRUGS
- Cariprazine (RGH-188), a potent D3/D2 dopamine receptor partial agonist, binds to dopamine D3 receptors in vivo and shows antipsychotic-like and procognitive effects in rodents
- (2011) István Gyertyán et al. NEUROCHEMISTRY INTERNATIONAL
- The Physiology, Signaling, and Pharmacology of Dopamine Receptors
- (2011) J.-M. Beaulieu et al. PHARMACOLOGICAL REVIEWS
- Current perspectives on the selective regulation of dopamine D2 and D3 receptors
- (2010) Dong Im Cho et al. ARCHIVES OF PHARMACAL RESEARCH
- Cognition and disability in bipolar disorder: lessons from schizophrenia research
- (2010) Philip D Harvey et al. BIPOLAR DISORDERS
- Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
- (2010) Richard Mailman et al. CURRENT PHARMACEUTICAL DESIGN
- Cariprazine (RGH-188), a Dopamine D3 Receptor-Preferring, D3/D2 Dopamine Receptor Antagonist-Partial Agonist Antipsychotic Candidate: In Vitro and Neurochemical Profile
- (2010) B. Kiss et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Enhanced cognitive performance of dopamine D3 receptor “knock-out” mice in the step-through passive-avoidance test: Assessing the role of the endocannabinoid/endovanilloid systems
- (2010) Vincenzo Micale et al. PHARMACOLOGICAL RESEARCH
- Antipsychotic Drugs for First-Episode Schizophrenia
- (2009) Kayvon Salimi et al. CNS DRUGS
- Asenapine exerts distinctive regional effects on ionotropic glutamate receptor subtypes in rat brain
- (2009) Frank I. Tarazi et al. SYNAPSE
- Asenapine induces differential regional effects on serotonin receptor subtypes
- (2008) FI Tarazi et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Subnanomolar dopamine D3 receptor antagonism coupled to moderate D2 affinity results in favourable antipsychotic-like activity in rodent models: II. behavioural characterisation of RG-15
- (2008) István Gyertyán et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection
- (2008) J. A. Lieberman et al. PHARMACOLOGICAL REVIEWS
- Differential regional and dose-related effects of asenapine on dopamine receptor subtypes
- (2008) Frank I. Tarazi et al. PSYCHOPHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search